George S Sheppard

USPTO Granted Patents = 36 (Patent Applications = 23)

CIPO Patents = 4 (Patent Applications = 19)

EPO Patents = 12 (Patent Applications = 24)

Average Co-Inventor Count = 7.2

ph-index = 9

Forward Citations = 350(Granted Patents)

Location History:

Willmette, IL (US) (2001)
Wilmette, IL (US) (1992 - 2020)

Company Filing History:

20 out of 4,179

Abbott Laboratories Corporation

Years Active: 1992-2020

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10633379 - Bromodomain inhibitors (2020-04-28),

2. 10131657 - Bromodomain inhibitors (2018-11-20),

3. 10085985 - Bromodomain inhibitors (2018-10-02),

4. 10035800 - Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors (2018-07-31),

5. 9957263 - Bromodomain inhibitors (2018-05-01),

6. 9776990 - Isoindolone derivatives (2017-10-03),

7. 9567339 - Primary carboxamides as BTK inhibitors (2017-02-14),

8. 9561231 - Pyridinone and pyridazinone derivatives (2017-02-07),

9. 9493411 - Pyrrole-3-carboxamide bromodomain inhibitors (2016-11-15),

10. 9428514 - Bromodomain inhibitors (2016-08-30),

11. 9321764 - Dihydro-pyrrolopyridinone inhibitors (2016-04-26),

12. 9296741 - Bromodomain inhibitors (2016-03-29),

13. 9051315 - Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition (2015-06-09),

14. 9050346 - Bromodomain inhibitors (2015-06-09),

15. 8536180 - Pyrimidine inhibitors of kinase activity (2013-09-17),

Title: **George S. Sheppard: Innovator in the Pharmaceutical Field**

Introduction

George S. Sheppard, based in Wilmette, IL, is a notable inventor with an impressive portfolio of 36 patents. His contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases, showcase his relentless pursuit of innovation.

Latest Patents

Sheppard's recent patents focus primarily on bromodomain inhibitors. These compounds, defined by specific formulas, serve as potential treatments for a variety of ailments including inflammatory diseases, cancer, and AIDS. His work not only details the chemical structures of these compounds but also includes pharmaceutical compositions that incorporate them. This significant research positions Sheppard as a key player in advancing therapeutic options for serious health conditions.

Career Highlights

Throughout his career, George S. Sheppard has made substantial contributions while working at leading companies such as Abbott Laboratories Corporation and AbbVie Inc. His expertise and innovative spirit have helped in advancing pharmaceutical research and development within these prestigious organizations.

Collaborations

In his journey as an inventor, Sheppard has collaborated with several talented professionals, including Keith F. McDaniel and Robert A. Mantei. These partnerships have not only enhanced his research but also contributed to a richer understanding of pharmaceutical innovations.

Conclusion

George S. Sheppard stands out as a prominent inventor within the pharmaceutical industry. His numerous patents, especially in the area of bromodomain inhibitors, underscore his dedication to improving health outcomes through innovative therapies. With his impressive track record and collaborative efforts, Sheppard continues to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.